EUVIMED · CrossrefZeitschrift
Pharmacotherapy in Psychiatry and Neurology
ISSN 1234-8279 · Termedia Sp. z.o.o.
Neueste Artikel
Psilocybin-assisted therapy for alcohol use disorder: A systematic review of randomized controlled trials
Purinergic system in the pathogenesis and treatment of mood disorders
Pharmacotherapy and psychotherapy for bipolar disorder in the context of early childhood trauma
Interdependence between digestive system diseases and mental disorders: The importance of a holistic approach in internal medicine practice
Association between prenatal medication exposure and the risk of autism spectrum disorder (ASD): A review
Shedding new light on anorexia nervosa: The therapeutic promise of the orexin system
Efficacy and safety of Withania somnifera in reducing stress and anxiety in adults: A narrative review
Accelerated, augmented, and precision-targeted: The emerging landscape of transcranial magnetic stimulation (TMS) in psychiatry and neurology
Zolpidem in the treatment of insomnia: Mechanism of action, risk of dependence, and withdrawal syndrome
Why we keep treating chronic migraine as a single disease
Role of zolpidem as a first-line treatment for insomnia in end-stage kidney disease: A review of efficacy and safety
Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies
A pill for loneliness? From biological mechanisms to precision interventions
From one-size-fits-all to precision therapeutics in psychiatry and neurology
Body dysmorphic disorder or dysmorphophobia recognition and contemporary treatment
Investigating limbic–hypothalamic functional connectivity and stress-induced neurochemical changes: Sex differences in response to stress and non-pharmacological intervention strategies
GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?
Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design
Pre-stroke psychological stress in relation to pre-stroke sleep parameters and early post-stroke cognitive performance in mild ischaemic stroke: An observational study
Medication adherence and long-acting injectable antipsychotics for the treatment of bipolar disorder
Editorial
Lurasidone – pharmacodynamic and pharmacokinetic properties, clinical potential and interaction risk
Sleep deprivation with sleep phase advance in treatment-resistant depression therapy in relation to features of circadian rhythm and temperament – a pilot study
Melatonin in the treatment of Circadian Rhythm Sleep-Wake Disorders – the principles of choosing the right time and dose of administration
Adverse effects of venlafaxine therapy and risk factors for their occurrence
Report: ECNP School of Neuropharmacology, 24–29 June 2018, Oxford
Report of the 6th ECNP School of Child and Adolescent Neuropsychopharmacology (Venice, Italy, 8th–13th April 2018)
Report on the ECNP Workshop on Clinical Research Methods, 6–8 November 2019, Barcelona, Spain
Editorial
Cerebrolysin – mechanism of action and application in psychiatry and neurology
EUVIMED